![Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422000460-ga1.jpg)
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect
![EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway | Oncogene EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41388-019-1036-7/MediaObjects/41388_2019_1036_Fig4_HTML.png)
EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway | Oncogene
![Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells | Oncogenesis Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells | Oncogenesis](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Foncsis.2014.17/MediaObjects/41389_2014_Article_BFoncsis201417_Fig1_HTML.jpg)
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells | Oncogenesis
Proteomic Analyses Identify a Novel Role for EZH2 in the Initiation of Cancer Cell Drug Tolerance | Journal of Proteome Research
![Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas - ScienceDirect Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124719314056-gr1.jpg)
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas - ScienceDirect
![Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors | Oncogene Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors | Oncogene](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2015.114/MediaObjects/41388_2016_Article_BFonc2015114_Fig2_HTML.jpg)
Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors | Oncogene
![The current described roles of EZH2 and KDM6B. EZH2 methyltransferase... | Download Scientific Diagram The current described roles of EZH2 and KDM6B. EZH2 methyltransferase... | Download Scientific Diagram](https://www.researchgate.net/publication/329817024/figure/fig1/AS:706079486922752@1545353876307/The-current-described-roles-of-EZH2-and-KDM6B-EZH2-methyltransferase-activity-which.png)